Macrophage migration inhibitory factor (MIF) is a multifunctional protein and a major mediator of innate immunity. Although X-ray crystallography revealed that MIF exists as a homotrimer, its oligomerization state in vivo and the factors governing its oligomerization and stability remain poorly understood. The C-terminal region of MIF is highly conserved and participates in several intramolecular interactions that suggest a role in modulating the stability and biochemical activity of MIF. To determine the importance of these interactions, point mutations (A48P, L46A), insertions (P107) at the monomer-monomer interfaces, and C-terminal deletion (Delta 110-114NSTFA and Delta 105-114NVGWNNSTFA) variants were designed and their structural properties, thermodynamic stability, oligomerization state, catalytic activity and receptor binding were characterized using a battery of biophysical methods. The C-terminal deletion mutants DeltaC5 huMIF 1-109 and DeltaC10 huMIF 1-104 were enzymatically inactive and thermodynamically less stable than wild type MIF. Analytical ultracentrifugation studies demonstrate that both C-terminal mutants sediment as trimers and exhibit similar binding to CD74 as the wild type protein. Disrupting the conformation of the C-terminal region 105-114 and increasing its conformational flexibility through the insertion of a proline residue at position 107 was sufficient to reproduce the structural, biochemical and thermodynamic properties of the deletion mutants. P107 MIF forms an enzymatically inactive trimer and exhibits reduced thermodynamic stability relative to the wild type protein. To provide a rationale for the changes induced by these mutations at the molecular level, we also performed molecular dynamics simulations on these mutants in comparison to the wild type MIF. Together, our studies demonstrate that intersubunit interactions involving the C-terminal region 105-114, including a salt-bridge interaction between Arg73 of one monomer and the carboxy terminus of a neighboring monomer, play critical roles in modulating tertiary structure stabilization, enzymatic activity, and thermodynamic stability of MIF, but not its oligomerization state and receptor binding properties. Our results suggest that targeting the C-terminal region could provide new strategies for allosteric modulation of MIF enzymatic activity and the development of novel inhibitors of MIF tautomerase activity.
Macrophage migration inhibitory factor (n class="Gene">MIF) is a multifunctional protein and a major mediator of innate immunity. Although X-ray crystallography revealed that MIF exists as a homotrimer, its oligomerization state in vivo and the factors governing its oligomerization and stability remain poorly understood. The C-terminal region of MIF is highly conserved and participates in several intramolecular interactions that suggest a role in modulating the stability and biochemical activity of MIF. To determine the importance of these interactions, point mutations (A48P, L46A), insertions (P107) at the monomer-monomer interfaces, and C-terminal deletion (Delta 110-114NSTFA and Delta 105-114NVGWNNSTFA) variants were designed and their structural properties, thermodynamic stability, oligomerization state, catalytic activity and receptor binding were characterized using a battery of biophysical methods. The C-terminal deletion mutants DeltaC5 huMIF 1-109 and DeltaC10 huMIF 1-104 were enzymatically inactive and thermodynamically less stable than wild type MIF. Analytical ultracentrifugation studies demonstrate that both C-terminal mutants sediment as trimers and exhibit similar binding to CD74 as the wild type protein. Disrupting the conformation of the C-terminal region 105-114 and increasing its conformational flexibility through the insertion of a proline residue at position 107 was sufficient to reproduce the structural, biochemical and thermodynamic properties of the deletion mutants. P107MIF forms an enzymatically inactive trimer and exhibits reduced thermodynamic stability relative to the wild type protein. To provide a rationale for the changes induced by these mutations at the molecular level, we also performed molecular dynamics simulations on these mutants in comparison to the wild type MIF. Together, our studies demonstrate that intersubunit interactions involving the C-terminal region 105-114, including a salt-bridge interaction between Arg73 of one monomer and the carboxy terminus of a neighboring monomer, play critical roles in modulating tertiary structure stabilization, enzymatic activity, and thermodynamic stability of MIF, but not its oligomerization state and receptor binding properties. Our results suggest that targeting the C-terminal region could provide new strategies for allosteric modulation of MIF enzymatic activity and the development of novel inhibitors of MIF tautomerase activity.
Authors: N Yabunaka; J Nishihira; Y Mizue; M Tsuji; M Kumagai; Y Ohtsuka; M Imamura; M Asaka Journal: Diabetes Care Date: 2000-02 Impact factor: 19.112
Authors: T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser Journal: Nat Med Date: 2000-02 Impact factor: 53.440
Authors: Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala Journal: Am J Pathol Date: 2003-01 Impact factor: 4.307
Authors: R Kleemann; A Hausser; G Geiger; R Mischke; A Burger-Kentischer; O Flieger; F J Johannes; T Roger; T Calandra; A Kapurniotu; M Grell; D Finkelmeier; H Brunner; J Bernhagen Journal: Nature Date: 2000-11-09 Impact factor: 49.962
Authors: M Orita; S Yamamoto; N Katayama; M Aoki; K Takayama; Y Yamagiwa; N Seki; H Suzuki; H Kurihara; H Sakashita; M Takeuchi; S Fujita; T Yamada; A Tanaka Journal: J Med Chem Date: 2001-02-15 Impact factor: 7.446
Authors: G Fingerle-Rowson; O Petrenko; C N Metz; T G Forsthuber; R Mitchell; R Huss; U Moll; W Müller; R Bucala Journal: Proc Natl Acad Sci U S A Date: 2003-07-23 Impact factor: 11.205
Authors: M E Pyle; M Korbonits; M Gueorguiev; S Jordan; B Kola; D G Morris; A Meinhardt; M P Powell; F X Claret; Q Zhang; C Metz; R Bucala; A B Grossman Journal: J Endocrinol Date: 2003-01 Impact factor: 4.286
Authors: Lin Leng; Christine N Metz; Yan Fang; Jing Xu; Seamas Donnelly; John Baugh; Thomas Delohery; Yibang Chen; Robert A Mitchell; Richard Bucala Journal: J Exp Med Date: 2003-06-02 Impact factor: 14.307
Authors: Melanie Merk; Swen Zierow; Lin Leng; Rituparna Das; Xin Du; Wibke Schulte; Juan Fan; Hongqi Lue; Yibang Chen; Huabao Xiong; Frederic Chagnon; Jürgen Bernhagen; Elias Lolis; Gil Mor; Olivier Lesur; Richard Bucala Journal: Proc Natl Acad Sci U S A Date: 2011-08-04 Impact factor: 11.205
Authors: Roberto Meza-Romero; Gil Benedek; Lin Leng; Richard Bucala; Arthur A Vandenbark Journal: Metab Brain Dis Date: 2016-02-06 Impact factor: 3.584
Authors: Guanggang Qu; Raymond Fetterer; Lin Leng; Xin Du; Dante Zarlenga; Zhiqiang Shen; Wenyu Han; Richard Bucala; Wenbin Tuo Journal: Int J Parasitol Date: 2014-02-28 Impact factor: 3.981
Authors: Garry W Buchko; Jan Abendroth; Howard Robinson; Yanfeng Zhang; Stephen N Hewitt; Thomas E Edwards; Wesley C Van Voorhis; Peter J Myler Journal: J Struct Funct Genomics Date: 2013-05-25
Authors: Chengpeng Fan; Deepa Rajasekaran; Mansoor Ali Syed; Lin Leng; J Patrick Loria; Vineet Bhandari; Richard Bucala; Elias J Lolis Journal: Proc Natl Acad Sci U S A Date: 2013-06-17 Impact factor: 11.205
Authors: Sarah E Dobson; Kevin D Augustijn; James A Brannigan; Claudia Schnick; Chris J Janse; Eleanor J Dodson; Andrew P Waters; Anthony J Wilkinson Journal: Protein Sci Date: 2009-12 Impact factor: 6.725